Company Name: |
Hangzhou Peptidego Biotech Co.,Ltd.
|
Tel: |
0571-87213919 |
Email: |
Eric@peptidego.com |
Products Intro: |
Product Name:Heart-homing peptide CAS:876460-72-9 Purity:95% or 98% HPLC Package:1mg;5mg;10mg;50mg;100mg,1g or according to customer's detail requirement.
|
Company Name: |
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
|
Tel: |
0571-87213919 17306812703 |
Email: |
3007955328@qq.com |
Products Intro: |
Product Name:Heart-homing peptide CAS:876460-72-9 Purity:95% or 98% HPLC Package:1mg;5mg;10mg;50mg;100mg,1g or according to customer's detail requirement.
|
|
| L-Arginine, L-cysteinyl-L-arginyl-L-prolyl-L-prolyl- Basic information |
| L-Arginine, L-cysteinyl-L-arginyl-L-prolyl-L-prolyl- Chemical Properties |
density | 1.59±0.1 g/cm3(Predicted) | pka | 3.60±0.21(Predicted) |
| L-Arginine, L-cysteinyl-L-arginyl-L-prolyl-L-prolyl- Usage And Synthesis |
Uses | Heart-homing peptide is a peptide, CRPPR. CRPPR is a linear peptide containing arginine that has been identified as a heart-homing peptide owing to its ability to specifically bind to heart endothelium, and cysteine-rich protein-2 (CRIP-2) has been proposed as the receptor. Heart-homing peptide can be used for conjugating liposomes[1][2]. | References | [1] Zhang H, et al. The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium. J Control Release. 2012 Oct 10;163(1):10-7. DOI:10.1016/j.jconrel.2012.06.038 [2] Rodríguez-Castejón J, et al. Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug Deliv Transl Res. 2024 Apr 8. DOI:10.1007/s13346-024-01583-0 |
| L-Arginine, L-cysteinyl-L-arginyl-L-prolyl-L-prolyl- Preparation Products And Raw materials |
|